Evidence map›Paper›PMID 27021036›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2017

Colonization With Antimicrobial-Resistant Gram-Negative Bacilli at Neonatal Intensive Care Unit Discharge.

Sarah A Clock, Yu-Hui Ferng, Setareh Tabibi, Luis Alba, Sameer J Patel, Haomiao Jia, Patricia DeLaMora, Jeffrey M Perlman, David A Paul, Theoklis Zaoutis and 2 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03079245 (Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03079245 nacompletednot on this map

Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit

TypeinterventionalSponsorColumbia UniversityRan2009 to 2012Enrolled6,184ConditionsInfants in Neonatal Intensive Care UnitsArmsEducation Plus (E+), Clinical Decision Support, Prescriber Audit and Feedback
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sarah A ClockDepartment of Pediatrics.
Yu-Hui FerngSchool of Nursing, Columbia University Medical Center.
Setareh TabibiDepartment of Pediatrics.
Luis AlbaDepartment of Pediatrics.
Sameer J PatelDepartment of Pediatrics.
Haomiao JiaSchool of Nursing, Columbia University Medical Center.
Patricia DeLaMoraDepartment of Pediatrics, Weill Cornell Medical College, New York, New York.
Jeffrey M PerlmanDepartment of Pediatrics, Weill Cornell Medical College, New York, New York.
David A PaulDepartment of Pediatrics, Section of Neonatology, Christiana Care Health System, Newark, Delaware.
Theoklis ZaoutisChildren's Hospital of Philadelphia, Pennsylvania.
Elaine L LarsonSchool of Nursing, Columbia University Medical Center.
Lisa SaimanDepartment of Pediatrics.
Columbia University Irving Medical Center · USCornell University · USChildren's Hospital of Philadelphia · USChristiana Care Health System · USNew York Hospital Queens · US

Funding

Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care UnitR01NR010821 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SAIMAN, LISA · 2008 to 2012
$4.6M
NINR NIH HHS R01 NR010821
6 · The paper itself

Abstract

backgroundThe epidemiology of the colonization of infants with antimicrobial-resistant Gram-negative bacilli (GNB) at discharge from the neonatal intensive care unit (NICU) is not well understood.

methodsA multicenter study in which rectal surveillance samples for culture were obtained at NICU discharge from infants hospitalized ≥14 days was performed. Factors associated with colonization with GNB resistant to gentamicin, third/fourth-generation cephalosporin agents, or carbapenem agents were assessed by using a fixed-effects model.

resultsOf these infants, 9% (119 of 1320) were colonized with ≥1 antimicrobial-resistant GNB. Prolonged treatment (≥10 days) with meropenem or third/fourth-generation cephalosporin agents or treatment for ≥5 days with a β-lactam/β-lactamase combination agent were associated with an increased risk of colonization with GNB resistant to gentamicin. Surgery and ≥5 days of treatment with third/fourth-generation cephalosporin agents, a β-lactam/β-lactamase combination agent, or metronidazole were associated with an increased risk of colonization with GNB resistant to third/fourth-generation cephalosporin agents. Female sex and prolonged treatment (≥10 days) with meropenem were associated with colonization with GNB resistant to carbapenem agents.

conclusionsProlonged treatment with broad-spectrum antibiotics was associated with the colonization of infants with antimicrobial-resistant GNB within 7 days of NICU discharge. These findings suggest the potential for dissemination of resistant GNB from colonized infants to other NICUs, the community, or pediatric long-term care facilities. Antimicrobial stewardship efforts aimed at improving appropriate antibiotic use could have a beneficial effect on the emergence of antimicrobial-resistant GNB in the NICU population.

Indexed as

Anti-Bacterial AgentsCross InfectionDrug Resistance, BacterialFemaleGram-Negative Bacterial InfectionsHumansInfant, NewbornInfant, Newborn, DiseasesIntensive Care Units, NeonatalMalePatient DischargeRisk FactorsAnti-Bacterial Agentsantimicrobial resistancecephalosporin agentsgentamicinmeropenemrisk factors

Identifiers

PMID27021036
PMCPMC5907870
OpenAlexW2334595384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.